Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia

New Microbes and New Infections

Volumn 2, Issue 4, 2014, Pages 88-92

  Rahman, B A ^a   Wasfy, M O ^a   Maksoud, M A ^a   Hanna, N ^b   Dueger, E ^a,c   House, B ^a  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b Public Health Consultant   (Egypt)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Decreased ciprofloxacin susceptibility; Fluoroquinolone resistance; Multidrug resistant typhoid; Nalidixic acid resistance; Salmonella typhi

Indexed keywords

AMPICILLIN; BENACTYZINE; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIA; BACTERIUM ISOLATION; DISEASE SURVEILLANCE; DISK DIFFUSION; INCIDENCE; MIDDLE EAST; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; TREATMENT FAILURE; TYPHOID FEVER;

SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

EID: 84921985728     PISSN: 20522975     EISSN: None     Source Type: Journal    
DOI: 10.1002/nmi2.46     Document Type: Review

References (28)

1. Mirza SH, Beeching NJ, Hart CA. Multi-drug resistant typhoid: a global problem. J Med Microbiol 1996; 44: 317-319.
2. Crump JA, Youssef FG, Luby SP, Wasfy MO. Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. J Emerg Infect Dis 2003; 9: 539-544.
3. Bakr WM, El Attar LA, Ashour MS, El Toukhy AM. The dilemma of widal test-which brand to use? A study of four different widal brands: a cross sectional comparative study. Ann Clin Microbiol Antimicrob 2011; 10: 7-15.
4. Korzeniewski K. The epidemiological situation in Iraq. Przegl Epidemiol 2006; 60: 845-855.
5. Al-Sanouri TM, Paglietti B, Haddadin A et al. Emergence of plasmid-mediated multidrug resistance in epidemic and non-epidemic strains of Salmonella enterica serotype Typhi from Jordan. J Infect Dev Ctries 2008; 2: 295-301.
6. Kothari A, Pruthi A, Chugh TD. The burden of enteric fever. J Infect Dev Count 2008; 2: 253-259.
7. Srikantiah P, Vafokulov S, Luby SP et al. Epidemiology and risk factors for endemic typhoid fever in Uzbekistan. Trop Med Int Health 2007; 12: 838-847.
8. El-Sherbini A. An outbreak of typhoid fever resistant to chloramphenicol and other drugs in Gharbeya governorate in Egypt. J Trop Pediatr 1992; 38: 331-334.
9. WasfyMO,Frenck R, Ismail TF,Mansour H,Malone JI,MahoneyFJ. Trends of multiple-drug resistance among Salmonella Serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35: 1265-1268.
10. Hammad OM, Abdel Wahab MF, Zaky S, Abdel Baki AM, Afify A, El Tantawi MA. Multidrug resistant typhoid fever in Egypt. J Med Lab Sci 2007; 16: 57-63.
11. Afifi S, Earhart K, Azab MA et al. Hospital-based surveillance for acute febrile illness in Egypt: a focus on community-acquired bloodstream infections. Am J Trop Med Hyg 2005; 73: 392-399.
12. Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res 2004; 120: 111-114.
13. Hammad OM, Hifnawy T, Omran D, El Tantawi MA, Girgis NI. Ceftriaxone versus chloramphenicol for treatment of acute typhoid fever. Life Sci J 2011; 8: 100-105.
14. Asna SM, Haq JA, Rahman MM. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. Jpn J Infect Dis 2003; 56: 32-33.
15. Rupali P, Abraham OC, Jesudason MV et al. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis 2004; 49: 1-3.
16. Kumar Y, Sharma A, Mani KR. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India. J Infect Dev Ctries 2009; 3: 467-469.
17. Ray P, Sharma J, Marak RSK, Garg RK. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica serovar Typhi. Indian J Med Res 2006; 124: 105-108.
18. Nagshetty K, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries 2010; 4: 70-73.
19. Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica Serotype Typhi in Eastern Nepal. J Health Popul Nutr 2007; 25: 82-87.
20. Kownhar H, Shankar EM, Rajan R, Rao UA. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 2007; 56: 136-137.
21. WHO Background document. The diagnosis, treatment and prevention of typhoid fever. Geneva, World Health Organization Communicable Disease Surveillance and Response. WHO/V&B/03.07 2003.
22. Rotimi VO, Jamal W, Pal T, Sonnevend A, Dimitrov TS, Albert MJ. Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates. Diagn Microbiol Infect Dis 2008; 60: 71-77.
23. Wasfy MO, Oyofo BA, David JC et al. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J Health Popul Nutr 2000; 18: 33-38.
24. Parry C, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 2002; 347: 1770-1782.
25. Saha SK, Talukder SY, Islam M, Saha S. A highly ceftriaxone-resistant Salmonella Typhi in Bangladesh. Pediatr Infect Dis J 1999; 18: 387.
26. Naiemi NA, Zwart B, Rijnsburger MC, Roosendaal R, Debets-Ossenkopp YJ, Mulder JA. Extended-spectrum-b-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol 2008; 46: 2794-2795.
27. Renuka K, Sood S, Das BK, Kapil A. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 2005; 54: 999-1000.
28. Harish BN, Menezes GA, Sarangapani K, Parija SC. A case report and review of the literature: ciprofloxacin resistant Salmonella enterica serovar Typhi in India. J Infect Dev Ctries 2008; 2: 324-327.